Vibration therapy for cerebral palsy childre

Not Applicable

Completed

• Conditions: Cerebral palsy; Neurological - Other neurological disorders

• Registration Number: ACTRN12618002026202
• Lead Sponsor: Prof Paul Hofman

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-12-18
• Study Completion: 2021-10-23
• Last Update Posted: 6 June 2022

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 34

Inclusion Criteria

Have diagnosed cerebral palsy with GMFCS I - III
- Be able to safely stand on the vibration platform
- Be able to understand the researcher’s instructions and follow them

Exclusion Criteria

- A bone fracture within 12 weeks of enrolment
- Acute thrombosis, tendinitis, nephrolithiasis, discopathy or arthritis
- History of clinically significant organic disease or findings on physical examination, which in the opinion of the Investigator would prevent the patient from completing the study.
- History of using any of the following medications, regardless of dose, for at least 1 month, within 3 months of enrolment: anabolic agents, glucocorticoids (does not include inhaled glucocorticoids) or growth hormone.
- History of botulinum toxin injection into lower limbs within 3 months of enrollment

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Mobility as assessed by the 6-minute walk test[Baseline (T0); after 12 weeks of control period (T1); after 12 weeks of vibration therapy (T2); after completing 20 weeks of vibration therapy (T3) (primary endpoint); in 12 weeks after finishing intervention period (T4).]